Profile data is unavailable for this security.
About the company
Intervacc AB is a Sweden-based biotechnology company. It develops vaccines based on recombinant proteins for animal health care. The Company’s candidate vaccine against strangles Strangvac consists of soluble recombinant proteins and devoids any living infectious agent. The Company operates through two subsidiaries: Nord Vacc Lakemedel AB and Mybac-Vettech AB. Nord Vacc Lakemedel AB markets and distributes veterinary vaccines, pharmaceuticals and vitamins on European market. It offers assortment of fur animal vaccines, the Febrivac range, as well as swine vaccines for Swedish and Danish markets. Mybac-Vettech AB is a technology platform that focuses on diagnostics in the Swedish animal health market and offers bacteriological and mycological analyses.
- Revenue in SEK (TTM)8.02m
- Net income in SEK-102.85m
- Incorporated1983
- Employees15.00
- LocationIntervacc ABVastertorpsvagen 135HAGERSTEN 129 44SwedenSWE
- Phone+46 812010600
- Fax+46 812010640
- Websitehttp://intervacc.se/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abliva AB | 137.00k | -95.51m | 231.23m | 6.00 | -- | 2.57 | -- | 1,687.84 | -0.0904 | -0.0904 | 0.0001 | 0.067 | 0.001 | -- | 0.0034 | -- | -70.40 | -74.59 | -80.95 | -86.98 | -14,491.24 | -- | -69,714.60 | -65,958.89 | -- | -- | 0.00 | -- | 341.94 | 93.89 | -12.02 | -- | -19.74 | -- |
Ultimovacs ASA | 0.00 | -187.29m | 237.69m | 27.00 | -- | 0.8596 | -- | -- | -5.50 | -5.50 | 0.00 | 8.12 | 0.00 | -- | -- | 0.00 | -44.08 | -28.80 | -50.02 | -31.12 | -- | -- | -- | -- | -- | -- | 0.0131 | -- | -- | -- | -12.78 | -- | -45.35 | -- |
SynAct Pharma AB | 0.00 | -215.81m | 243.31m | 5.00 | -- | 1.38 | -- | -- | -6.54 | -6.54 | 0.00 | 4.95 | 0.00 | -- | -- | 0.00 | -116.46 | -125.17 | -130.53 | -151.70 | -- | -- | -- | -- | -- | -- | 0.0036 | -- | -- | -- | -117.54 | -- | -- | -- |
Thor Medical ASA | 0.00 | -5.50m | 245.01m | 1.00 | -- | 0.9104 | -- | -- | -0.0318 | -0.152 | 0.00 | 1.16 | 0.00 | -- | -- | 0.00 | -2.52 | -79.17 | -2.84 | -113.94 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
Arctic Bioscience AS | 33.40m | -45.05m | 246.07m | 20.00 | -- | 0.9616 | -- | 7.37 | -1.79 | -1.79 | 1.33 | 10.19 | 0.1075 | 0.7025 | 2.93 | 1,687,501.00 | -14.50 | -- | -16.61 | -- | 28.96 | -- | -134.86 | -- | 2.53 | -- | 0.0079 | -- | -1.52 | -- | -33.77 | -- | -- | -- |
Lumito AB (publ) | 0.00 | -25.80m | 259.29m | 15.00 | -- | 2.51 | -- | -- | -0.125 | -0.125 | 0.00 | 0.4997 | 0.00 | -- | -- | 0.00 | -19.98 | -20.77 | -22.14 | -22.38 | -- | -- | -- | -- | 1.42 | -- | 0.0884 | -- | -- | -- | 4.56 | -- | -- | -- |
Lipum AB (publ) | 0.00 | -37.18m | 260.81m | -- | -- | 14.81 | -- | -- | -4.05 | -4.05 | 0.00 | 0.4726 | 0.00 | -- | -- | -- | -159.35 | -127.85 | -206.31 | -184.50 | -- | -- | -- | -293,228.70 | -- | -- | 0.2781 | -- | -- | -- | 2.38 | -- | -- | -- |
Aqua Bio Technology ASA | 13.37m | -1.49m | 272.50m | 2.00 | -- | 12.80 | 318.07 | 20.38 | -0.1599 | -0.1599 | 0.4938 | 0.3673 | 0.3079 | 0.6548 | 9.01 | -- | -3.42 | -80.72 | -6.75 | -125.29 | 66.69 | 5.57 | -11.12 | -965.98 | 0.1044 | 0.611 | 0.7538 | -- | 349.88 | 42.04 | 1.97 | -- | -- | -- |
Lytix Biopharma AS | 3.95m | -87.03m | 280.33m | -- | -- | 4.43 | -- | 70.97 | -2.16 | -2.16 | 0.0981 | 1.26 | 0.037 | -- | 0.4091 | -- | -81.63 | -57.34 | -94.30 | -66.09 | -- | -- | -2,203.36 | -4,665.04 | -- | -- | -- | -- | 183.25 | 63.94 | -57.01 | -- | -- | -- |
Hamlet BioPharma AB | 0.00 | -26.59m | 315.58m | 7.00 | -- | 6.97 | -- | -- | -0.207 | -0.207 | 0.00 | 0.3543 | 0.00 | -- | -- | -- | -63.29 | -83.52 | -69.05 | -107.84 | -- | -- | -- | -- | -- | -- | 0.0984 | -- | -- | -- | -18.87 | -- | 78.01 | -- |
Intervacc AB | 8.02m | -102.85m | 318.47m | 15.00 | -- | 1.34 | -- | 39.73 | -1.47 | -1.47 | 0.1167 | 3.14 | 0.0306 | 3.08 | 1.72 | 534,333.30 | -39.21 | -17.62 | -42.12 | -18.77 | -628.60 | -243.59 | -1,283.24 | -626.90 | 4.38 | -- | 0.0006 | -- | -17.23 | -25.79 | -60.31 | -- | -38.72 | -- |
Magle Chemoswed Holding AB | 170.01m | 12.23m | 326.16m | 78.00 | 26.67 | 2.02 | 13.02 | 1.92 | 1.13 | 1.13 | 15.74 | 14.95 | 0.6068 | 0.493 | 8.30 | 2,179,628.00 | 4.36 | 2.52 | 5.86 | 3.52 | 90.58 | 85.67 | 7.19 | 3.92 | 0.6356 | 6.35 | 0.3081 | -- | 17.00 | 9.97 | 33.07 | -- | -6.34 | -- |
Herantis Pharma Oyj | 0.00 | 3.28m | 330.39m | 10.00 | 111.38 | 5.97 | 100.86 | -- | 0.0126 | 0.0126 | 0.00 | 0.2344 | 0.00 | -- | -- | 0.00 | 4.31 | -80.46 | 6.16 | -104.37 | -- | -- | -- | -- | -- | -- | 0.0073 | -- | -- | -- | 103.00 | -- | -- | -- |
Xbrane Biopharma AB | 238.73m | -322.03m | 331.13m | 93.00 | -- | 0.3323 | -- | 1.39 | -1.27 | -1.52 | 0.943 | 0.6516 | 0.3553 | 2.59 | 357.65 | 2,566,979.00 | -47.92 | -40.98 | -82.48 | -67.24 | 14.82 | -- | -134.89 | -364.40 | 1.09 | -- | 0.2466 | -- | 314.33 | 63.42 | -91.10 | -- | 60.02 | -- |
Medivir AB | 7.63m | -89.32m | 352.97m | 10.00 | -- | 1.51 | -- | 46.24 | -1.46 | -1.46 | 0.1127 | 2.09 | 0.0292 | -- | 2.73 | 763,300.00 | -34.22 | -28.91 | -41.03 | -34.77 | -802.20 | -467.42 | -1,170.21 | -675.96 | -- | -- | 0.0585 | -- | 73.16 | -20.39 | -0.6275 | -- | -47.96 | -- |
Ascelia Pharma AB | 0.00 | -109.29m | 357.16m | 13.00 | -- | 4.96 | -- | -- | -3.20 | -3.20 | 0.00 | 2.13 | 0.00 | -- | -- | 0.00 | -71.51 | -- | -85.53 | -- | -- | -- | -- | -- | -- | -- | 0.0141 | -- | -- | -- | 16.72 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Swedbank Robur Fonder ABas of 30 Jun 2023 | 5.13m | 6.77% |
Handelsbanken Fonder ABas of 30 Jun 2023 | 4.57m | 6.03% |
Fj�rde AP-fondenas of 30 Jun 2023 | 3.75m | 4.95% |
Aktia Bank Plc (Investment Management)as of 30 Jun 2023 | 1.16m | 1.53% |
Aktia Fondbolag Abas of 28 Mar 2024 | 1.16m | 1.53% |
Nordea Investment Management ABas of 30 Jun 2023 | 1.12m | 1.48% |
Aktie-Ansvar ABas of 30 Jun 2023 | 1.05m | 1.39% |
Mandarine Gestion SAas of 30 Jun 2023 | 700.00k | 0.92% |
Capital Research & Management Co. (World Investors)as of 31 Dec 2022 | 576.07k | 0.76% |
Lancelot Asset Management ABas of 30 Jun 2020 | 460.54k | 0.61% |